Group One Trading’s Keryx Biopharmaceuticals Inc KERX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q4 | – | Sell |
-6,876
| Closed | -$23K | – | 2460 |
|
|
2018
Q3 | $23K | Sell |
6,876
-39,446
| -85% | -$132K | ﹤0.01% | 1102 |
|
|
2018
Q2 | $174K | Buy |
+46,322
| New | +$174K | ﹤0.01% | 667 |
|
|
2018
Q1 | – | Sell |
-129,913
| Closed | -$604K | – | 2263 |
|
|
2017
Q4 | $604K | Sell |
129,913
-93,202
| -42% | -$433K | ﹤0.01% | 428 |
|
|
2017
Q3 | $1.58M | Buy |
223,115
+116,912
| +110% | +$830K | 0.01% | 226 |
|
|
2017
Q2 | $768K | Sell |
106,203
-53,929
| -34% | -$390K | 0.01% | 321 |
|
|
2017
Q1 | $986K | Sell |
160,132
-108,595
| -40% | -$669K | 0.01% | 238 |
|
|
2016
Q4 | $1.58M | Sell |
268,727
-19,342
| -7% | -$113K | 0.02% | 207 |
|
|
2016
Q3 | $1.53M | Buy |
288,069
+196,625
| +215% | +$1.04M | 0.02% | 150 |
|
|
2016
Q2 | $605K | Sell |
91,444
-92,734
| -50% | -$614K | 0.01% | 263 |
|
|
2016
Q1 | $860K | Buy |
184,178
+58,890
| +47% | +$275K | 0.01% | 201 |
|
|
2015
Q4 | $633K | Buy |
125,288
+75,439
| +151% | +$381K | 0.01% | 316 |
|
|
2015
Q3 | $175K | Sell |
49,849
-112,572
| -69% | -$395K | ﹤0.01% | 619 |
|
|
2015
Q2 | $1.62M | Buy |
162,421
+86,638
| +114% | +$865K | 0.02% | 149 |
|
|
2015
Q1 | $965K | Sell |
75,783
-76,717
| -50% | -$977K | 0.02% | 194 |
|
|
2014
Q4 | $2.16M | Buy |
152,500
+146,635
| +2,500% | +$2.08M | 0.03% | 102 |
|
|
2014
Q3 | $81K | Sell |
5,865
-218,014
| -97% | -$3.01M | ﹤0.01% | 791 |
|
|
2014
Q2 | $3.44M | Buy |
223,879
+215,919
| +2,713% | +$3.32M | 0.05% | 77 |
|
|
2014
Q1 | $136K | Sell |
7,960
-328,193
| -98% | -$5.61M | ﹤0.01% | 649 |
|
|
2013
Q4 | $4.35M | Buy |
336,153
+108,625
| +48% | +$1.41M | 0.07% | 44 |
|
|
2013
Q3 | $2.3M | Sell |
227,528
-58,694
| -21% | -$593K | 0.04% | 77 |
|
|
2013
Q2 | $2.14M | Buy |
+286,222
| New | +$2.14M | 0.05% | 64 |
|